biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Where’s our NR

<< Previous

Bullboard Posts

Next >>

Post by ronrydellon Oct 06, 2021 4:28pm

354 Views

Post# 33974994

Where’s our NR

I can't believe on a Weds...with the Goldman Sachs bio tech conference starting tomorrow....that we still have no news that prospective partners and attendee's can't cogitate on. Improssible to get responses from the Investor relations dept (?). or anywhere else....any comments here?

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand